investment

Fujifilm Invests in Two US Facilities

Fujifilm Diosynth Biotechnologies, a subsidiary of Japan’s Fujifilm Corp., has announced plans to spend more than $2 billion to build a new large-scale cell culture production site in the US to accelerate the growth of its biopharma CDMO business.

CEFIC’s Mid-Century Vision

ACG Launches new Capsules Manufacturing Plant in Brazil

MFG Chemical Upgrades Newly Acquired Pasadena, Texas Plant

Chemical Industry Welcomes Brexit Deal but Holds its Breath

Finding the Right Emerging Markets for Growth

Cambrex to Upgrade Generic API Manufacturing Facilities at Milan Site

Shintech Builds VCM/PVC Complex in USA

Perstorp proceeds with UK Caprolactone Upgrad

Jennewein Biotechnologie to Build New R&D Centre

Tatarstan - a Hot Spot of the Chemical Industry in Russia

Lonza Expands in US, Moves Some Production

Finland Relinquishes Control of Neste

Venezuela: Plenty of Room for Improvement

Swiss Biotech Sector Stimulates Growth

Business Opportunities in the US

Trade and Industry Investment of the US Chemical Sector

UK Chemical Companies Start to Fear the Worst with Brexit

Ireland’s Thriving Pharma and Chemicals Producers Optimistic about Brexit

The Italian Chemical Industry

Green Chemistry and Smart Chemistry

Regaining Competitiveness in the Global Market

Oman Oil Company and Kuwait Petroleum to Co-develop Duqm Refinery

ADC Bio to Invest $11m on Bioconjugation Facility

Taiwan Chemical Firms to Expand at Daesan

CordenPharma Expands Manufacturing Capacities for Veterinary Drug Products

Adnoc Seeks Partners on Stronger Petchems Focus

Arkema Outlines Forward-looking Goals

A Future-oriented Industrial Policy Strategy

Sibur Plans Plasticizer Plant in Perm, Russia

Kemira Expands Sizing Agents in China

Taiwan’s CPC Looks to Invest in US Shale

Ineos Plans Major Olefins Projects in Europe

Lubrizol Hikes Drug Product Manufacturing Capacity

Eastman Expands US Films Capacity